Loading stock data...
Cellectar Biosciences, Inc. (CLRB) Stock Price, Chart & Analysis
Cellectar Biosciences, Inc.CLRB
Market Closed$4.34
$-0.08-1.81%
CLRB Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for CLRB to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Cellectar Biosciences, Inc. (CLRB)
Loading chart data...
Is Cellectar Biosciences, Inc. (CLRB) Stock a Buy in 2025?
YES
BUY
Score: 68/100
Yes, CLRB stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether CLRB stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 982.9% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- High debt-to-equity ratio of 6.07
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$47.00
Upside Potential:982.9%
Investment Summary
CLRB presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 982.9% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 6.07, and consider their own risk tolerance and investment timeline.
Final Recommendation
BUY
Recommendation Score
Overall Score:68/100
Buy
Key Factors
- Very strong analyst buy consensus
- Very significant upside potential
- Wide analyst target range indicates uncertainty
- Extremely high debt levels
- Small-cap risks
- Debt-to-Market-Cap Ratio: 3.7% (Very Low)
Investment Decision
Based on our comprehensive analysis of CLRB's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
How to Invest in clrb Stock?
Quick Investment Insights for clrb
Low Volatility (Beta: 0.42)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Cellectar Biosciences, Inc.
Healthcare
Biotechnology
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's...
Employees
11
Market Cap
$12.40M